Chaophya Hospital in Bangkok - Thailand

Chaophya Hospital is a leading private health care institution in Thailand celebrating its 15th anniversary this year. It is incorporated in 1988 by a multidisciplinary team of physician specialists and health care institutions under the leadership of the late Senator Lt. Gen. Dr. Kovit Patakayon, M.D. From its very inception, the hospital was conceived as a tertiary care general hospital to provide high quality healthcare by specialists to both the local and international patients and this has always been the guiding principle in its conduct and development.

Located on 5.5 acres of land on the west bank of the famed Chaophya river, its namesake, which cut through the heart of Bangkok, the hospital is easily accessible by land and waterway. It is only fifteen minutes from Siriraj Hospital, the oldest and largest medical school in Thailand, from where the hospital draws its many expert and talented medical consultant physicians.

In 2002, in keeping with its adherence to good governance concept, Chaophya Hospital becomes a public company and administrative restructuring was carried out to bring in talented team of physician-cum-administrators and new partners. Since that time, the hospital has undertaken major renovation project investing more than 150 million baht for a major upgrade of medical equipment and facilities for both the outpatient and inpatient quarters. Under the leadership of Prof. Supachai Chaithiraphan, its chief executive officer and Heart Center director, Chaophya Hospital is privileged to be at ground zero of the innovative stem cell therapy for end-staged ischemic heart disease patients and a trailblazer in translating stem cell research from the laboratory bench to the patient's bedside. Since March, 2005, more than 40 patients from U.S., U.K., Southeast Asian and the Middle East regions have been treated successfully and it is expected that the number of patients will grow rapidly in the coming months.

Continually striving for excellence in medical cares and services, Chaophya Hospital will continually innovate to stay at the forefront of medical advances to provide a unique combination of world class medical care in conjunction with the famed Thai hospitality service. In collaboration with a leading biotechnology firm, Theravitae Co. Ltd., Chaophya Hospital is now offering state-of-the-art cell therapy for end-stage ischemic heart patients for the first time in Asia . Using circulating adult stem cells harvested from your own blood, the cells are separated from other blood cells and greatly expanded in number in the laboratory using GMP manufacturing standard. A week later, these cells, the angiogenic progenitor cells or APC's for short, are reinfused back into the blood vessels supplying blood flow to the heart muscle. The injected cells migrate out of the blood vessel's lumen and take hold in the ischemic muscle region where they stimulate the formation of new blood vessels to bring more blood flow to the neey heart muscle fibers. In addition to being precursor cells for blood vessels, some of the APC's are known to also morph into cardiac muscle cells, fuse with heart muscle fibers and secrete cytokines, molecules that provide the homing signals to recruit other cells and molecules to help rejuvenate the function of heart muscle. The beneficial effect becomes clinically discernable usually after one month and becomes maximal at 3-6 months.

Hospital Services:
Cardiac Program
Spine Center
Gastrointestinal-Liver Center
Check-up Programs
Aesthetic Center
24 hour Eye Center
Dental Center
Degenerative Lumbar Spinal Stenosis|
Cell Therapy for Ischemic Heart disease
Stem Cells Treatment of Cardiovascular disease

Contact:
113/44 Boromrachachonnee Road.
Bangkoknoi, Bangkok 10700
Tel.02-434-1111,02-434-0117,02-884-70000
Fax : 02-434-6929
Web: http://www.chaophya.com

Chaophya Hospital map with street view, see full screen map